These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22823969)

  • 21. Farnesoid X receptor modulators: a patent review.
    Crawley ML
    Expert Opin Ther Pat; 2010 Aug; 20(8):1047-57. PubMed ID: 20569093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in targeted therapeutic agents.
    Nicolaides NC; Sass PM; Grasso L
    Expert Opin Drug Discov; 2010 Nov; 5(11):1123-40. PubMed ID: 22827748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systems biology visualization tools for drug target discovery.
    Huan T; Wu X; Chen JY
    Expert Opin Drug Discov; 2010 May; 5(5):425-39. PubMed ID: 22823128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of phage display technology for the determination of the targets for small-molecule therapeutics.
    Takakusagi Y; Takakusagi K; Sugawara F; Sakaguchi K
    Expert Opin Drug Discov; 2010 Apr; 5(4):361-89. PubMed ID: 22823088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009).
    Leopoldo M; Lacivita E; Berardi F; Perrone R
    Expert Opin Ther Pat; 2010 Jun; 20(6):739-54. PubMed ID: 20476847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational systems approach for drug target discovery.
    Chandra N
    Expert Opin Drug Discov; 2009 Dec; 4(12):1221-36. PubMed ID: 23480463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A structural feature-based computational approach for toxicology predictions.
    Valerio LG; Yang C; Arvidson KB; Kruhlak NL
    Expert Opin Drug Metab Toxicol; 2010 Apr; 6(4):505-18. PubMed ID: 20074001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances with the use of bio-inspired vectors towards creation of artificial viruses.
    McCarthy HO; Wang Y; Mangipudi SS; Hatefi A
    Expert Opin Drug Deliv; 2010 Apr; 7(4):497-512. PubMed ID: 20151849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How can high-throughput screening deliver drugs to treat atherosclerosis?
    Yang Y; Wang L; Si S; Hong B
    Expert Opin Drug Discov; 2010 Dec; 5(12):1175-88. PubMed ID: 22822720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo design: balancing novelty and confined chemical space.
    Kutchukian PS; Shakhnovich EI
    Expert Opin Drug Discov; 2010 Aug; 5(8):789-812. PubMed ID: 22827800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of natural estrogen receptor modulators with structure-based virtual screening.
    Cao X; Jiang J; Zhang S; Zhu L; Zou J; Diao Y; Xiao W; Shan L; Sun H; Zhang W; Huang J; Li H
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3329-33. PubMed ID: 23608764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel GABA(B) receptor positive modulators: a patent survey.
    Froestl W
    Expert Opin Ther Pat; 2010 Aug; 20(8):1007-17. PubMed ID: 20645682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
    J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of targets and inhibitors of protein palmitoylation.
    Planey SL; Zacharias DA
    Expert Opin Drug Discov; 2010 Feb; 5(2):155-64. PubMed ID: 22822915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virtual Screening with AutoDock: Theory and Practice.
    Cosconati S; Forli S; Perryman AL; Harris R; Goodsell DS; Olson AJ
    Expert Opin Drug Discov; 2010 Jun; 5(6):597-607. PubMed ID: 21532931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in microfluidics for drug discovery.
    Lombardi D; Dittrich PS
    Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CGRP receptor antagonists: design and screening.
    Poyner DR; Hay DL; Conner AC
    Expert Opin Drug Discov; 2009 Dec; 4(12):1253-65. PubMed ID: 23480465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments.
    Soleilhac E; Nadon R; Lafanechere L
    Expert Opin Drug Discov; 2010 Feb; 5(2):135-44. PubMed ID: 22822913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel antibacterials.
    Miller JR; Waldrop GL
    Expert Opin Drug Discov; 2010 Feb; 5(2):145-54. PubMed ID: 22822914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.